Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-29 @ 3:41 AM
Study NCT ID:
NCT00402168
Status:
COMPLETED
Last Update Posted:
2017-01-05
First Post:
2006-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2009-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-20
First Submit QC Date:
None
Study First Post Date:
2006-11-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-11-10
Results First Submit QC Date:
None
Results First Post Date:
2017-01-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-05-03
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-11-07
Last Update Post Date:
2017-01-05
Last Update Post Date Type:
ESTIMATED